Millendo Therapeutics, Inc. (Nasdaq: MLND), a clinical-stage biopharmaceutical company developing novel treatments for orphan endocrine diseases, announced today that Julia C. Owens, Ph.D., President and Chief Executive Officer, will present at the Jefferies 2019 Healthcare Conference in New York City on Thursday, June 6, 2019 at 11:00 a.m. ET.
May 23, 2019
· 1 min read